Reproductive Health & Justice FOIA Request Filed Seeking Transparency in FDA’s Mifepristone Study Procurement Process June 30, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request has been filed with the Food and Drug Administration (FDA) seeking comprehensive documentation related to the solicitation and contract award procedures for the…
Reproductive Health & Justice FOIA Request Filed for Transparency in FDA’s Mifepristone Study Procurement Process June 17, 2026 Rifan Muazin A Freedom of Information Act (FOIA) request was submitted on June 9, 2026, to the Food and Drug Administration (FDA) seeking detailed information concerning the solicitation and contract award processes…
Reproductive Health & Justice Supreme Court Allows Telehealth Access to Mifepristone Amid Ongoing Legal Challenge June 15, 2026 Rifan Muazin The U.S. Supreme Court issued a critical order on May 14, 2026, permitting individuals to continue accessing the abortion pill mifepristone through telehealth services and mail delivery while a significant…
Reproductive Health & Justice The Center for Reproductive Rights Submits Comment Opposing Baseless Environmental Claims to Restrict Mifepristone Access June 15, 2026 Rifan Muazin The Center for Reproductive Rights has formally submitted a comprehensive comment to the Food and Drug Administration (FDA), vehemently opposing three Citizen Petitions put forth by the anti-abortion organization Students…
Reproductive Health & Justice The Center for Reproductive Rights Challenges Baseless Environmental Claims Used to Restrict Mifepristone Access June 4, 2026 Rifan Muazin The Center for Reproductive Rights (CRR) has formally lodged a strong objection with the Food and Drug Administration (FDA), challenging three Citizen Petitions submitted by the anti-abortion organization Students for…
Reproductive Health & Justice Center for Reproductive Rights Opposes "Baseless Environmental Claims" Targeting Mifepristone Access May 27, 2026 Rifan Muazin The Center for Reproductive Rights has formally submitted a detailed comment to the Food and Drug Administration (FDA) vehemently opposing three Citizen Petitions filed by the anti-abortion organization Students for…
Reproductive Health & Justice Supreme Court Temporarily Halts In-Person Dispensing Requirement for Abortion Pill Mifepristone May 26, 2026 Rifan Muazin The U.S. Supreme Court has issued a temporary administrative stay, pausing a restrictive ruling by the Fifth Circuit Court of Appeals that would have mandated in-person dispensing of the abortion…
Reproductive Health & Justice Supreme Court Pauses Restrictions on Telehealth Access to Abortion Pill Mifepristone Amid Ongoing Legal Battles May 22, 2026 Rifan Muazin The U.S. Supreme Court has issued a critical order allowing individuals to continue accessing the abortion medication mifepristone through telehealth services and subsequent delivery via mail or pickup at local…
Reproductive Health & Justice Supreme Court Allows Telehealth Access to Mifepristone Amid Ongoing Legal Challenge May 15, 2026 Rifan Muazin The U.S. Supreme Court has issued a pivotal order ensuring that individuals can continue to access the abortion pill mifepristone through telehealth services and receive it via mail or at…
Reproductive Health & Justice Telehealth Abortion Care Access Jeopardized as Court Temporarily Reinstates In-Person Dispensing Requirement for Mifepristone May 2, 2026 Rifan Muazin The landscape of reproductive healthcare in the United States faces a significant disruption following a recent ruling by the 5th Circuit Court of Appeals, which has temporarily reinstated a requirement…
